Knowledge, Attitudes and Practices toward Dengue Fever, Vector Control, and Vaccine Acceptance Among the General Population in Countries from Latin America and Asia Pacific: A Cross-Sectional Study (GEMKAP)
Author:
Shafie Asrul Akmal1ORCID, Moreira Edson Duarte2ORCID, Di Pasquale Alberta3, Demuth Dirk4ORCID, Yin Joanne Yoong Su5ORCID
Affiliation:
1. Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Science, Universiti Sains Malaysia, George Town 11800, Malaysia 2. Associação Obras Sociais Irmã Dulce Hospital Santo Antônio and Oswaldo Cruz Foundation, Brazilian Ministry of Health, Salvador 40420-000, Brazil 3. Regional Medical Affairs, Growth and Emerging Markets, Takeda Pharmaceuticals International AG Singapore Branch, Singapore 018981, Singapore 4. Evidence Generation and Publications, Growth and Emerging Markets, Takeda Pharmaceuticals International AG Singapore Branch, Singapore 018981, Singapore 5. Research for Impact, Singapore 159964, Singapore
Abstract
Dengue represents a major public health concern. With effective vaccines in development, it is important to identify motivational factors to maximize dengue vaccine uptake. A cross-sectional, quantitative, electronic survey was administered to a nationally representative adult population (n = 3800) in Argentina, Brazil, Colombia, Mexico, Indonesia, Malaysia, and Singapore. Willingness to vaccinate against dengue, and Knowledge, Attitudes, and Practices (KAP) toward dengue, vector control, prevention, and vaccination were determined. The Capability, Opportunity, Motivation for Behavior change (COM-B) framework was used to identify factors correlated with dengue vaccine(s) uptake. KAP scores (standardized, 0–100% scale) resulted in a low global score for Knowledge (48%) and Practice (44%), and a moderate score for Attitude (66%); scores were comparable across countries. Of all respondents, 53% had a high willingness (Score: 8–10/10) to vaccinate against dengue, which was higher (59%) in Latin America (Argentina, Brazil, Colombia, Mexico) than in Asia Pacific (40%) (Indonesia, Malaysia, Singapore). Key factors significantly (p < 0.05) associated with increased willingness to vaccinate included accessibility to the public (subsidies and incentives) and trust in the healthcare system and government. A common approach to dengue prevention across endemic countries––with some country-specific customization, including education, vaccination, and vector control (multi-pronged)––may reduce dengue burden and improve outcomes.
Funder
Takeda Pharmaceuticals International AG Singapore Branch
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference73 articles.
1. Tian, N., Zheng, J.X., Guo, Z.Y., Li, L.H., Xia, S., Lv, S., and Zhou, X.N. (2022). Dengue Incidence Trends and Its Burden in Major Endemic Regions from 1990 to 2019. Trop. Med. Infect. Dis., 7. 2. Lambrechts, L., Scott, T.W., and Gubler, D.J. (2010). Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission. PLoS Negl. Trop. Dis., 4. 3. Akbar, R. (2022, July 11). Ten threats to global health in 2019. Available online: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019. 4. World Health Organization (2022, July 11). Dengue and severe dengue. Available online: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue. 5. Global burden for dengue and the evolving pattern in the past 30 years;Yang;J. Travel. Med.,2021
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|